Dr. Pasi Janne, Dana-Farber Cancer Institute (IMAGE)

Dana-Farber Cancer Institute

Dr. Pasi Janne, Dana-Farber Cancer Institute

Caption

Pasi Janne, MD, PhD, and colleagues at Dana-Farber Cancer Institute have discovered a pair of backup circuits in cancer cells that enable the cells to dodge the effect of cetuximab. Until now, scientists haven't known why cancers that initially respond to cetuximab become resistant to it, or how to overcome such resistance.

Credit

Sam Ogden, Dana-Farber Cancer Institute

Usage Restrictions

None

License

Licensed content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.